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Abstract
Background: Computing polygenic risk scores (PRS) to pre-
dict the degree of risk for obesity may contribute to weight 
management programs strategically. Objectives: To investi-
gate the combined effect of FTO rs9930501, rs9930506, and 
rs9932754 and ADRB2 rs1042713 and rs1042714 using PRS 
on (1) the odds of obesity and (2) post-intervention differ-
ences in dietary, anthropometric, and cardiometabolic pa-
rameters in response to high-protein calorie-restricted, 
high-vitamin E, high-fiber (Hipcref) diet intervention in Ma-
laysian adults. Methods: Both a cross-sectional study (n = 
178) and a randomized controlled trial (RCT) (n = 128) were 
conducted to test the aforementioned objectives. PRS was 
computed as the weighted sum of the risk alleles possessed 
by each individual participant. Participants were stratified 
into first (PRS 0–0.64), second (PRS 0.65–3.59), and third (PRS 
3.60–8.18) tertiles. Results: The third tertile of PRS was asso-
ciated with significantly higher odds of obesity: 2.29 (95% 
CI = 1.11–4.72, adjusted p = 0.025) compared to the first ter-
tile. Indians (3.9 ± 0.3) had significantly higher PRS compared 
to Chinese (2.1 ± 0.4) (p = 0.010). In the RCT, a greater reduc-
tion in high-sensitivity C-reactive protein (hsCRP) levels was 
found in second and third tertiles after Hipcref diet interven-
tion compared to the control diet (p interaction = 0.048). 
Conclusion: Higher PRS was significantly associated with in-
creased odds of obesity. Individuals with higher PRS had a 
significantly greater reduction in hsCRP levels after Hipcref 
diet compared to the control diet. © 2020 The Author(s)
Published by S. Karger AG, Basel
Introduction
Genome-wide association studies have identified a 
large number of genes and gene variants that are associ-
ated with the development of obesity in many popula-
tions worldwide [1]. Genes involved in energy homeosta-
sis, adaptive thermogenesis, lipoprotein metabolism, ap-
petite control, and insulin signaling are some of the main 
candidate genes that have been studied in various popula-
tions. Further, it is now an accepted fact that obesity is a 
polygenic disorder (rarely monogenic), with many candi-
date gene variants contributing to the risk of increased 
This study was registered under the Medical Research and Eth-
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body weight and comorbidities [2]. As individual genetic 
variants generally confer only a moderate risk to a trait, 
analyzing multiple risk alleles simultaneously can be 
more informative and can enhance predictive power, par-
ticularly in polygenic conditions. A significant genotype 
effect between the number of risk alleles and the risk of 
abdominal obesity was identified in the LIPGENE-SU.
VI.MAX study, with approximately a 2.5-fold increased 
risk in individuals carrying two or more risk alleles com-
pared to individuals carrying one or no risk allele [3]. For 
most individuals genetic predisposition to metabolic dis-
ease has a polygenic basis [4].
Family and twin studies indicate that up to 50–90% of 
the variance in body mass index (BMI) is attributable to 
genetic factors [5]. Genetic factors also contribute to ap-
proximately 50% of the risk for type 2 diabetes mellitus 
(T2DM). Heritability rates of 10–30% for the metabolic 
syndrome (MetS) have been estimated [6, 7], indicating 
that these conditions are partly heritable. Nutrition and 
physical activity are key lifestyle factors that interact with 
genes and gene variants and promote the progression and 
pathogenesis of diet-related diseases. Excessive calorie in-
take and sedentary lifestyle promote the obese phenotype.
Emerging evidence from gene-diet interactions from 
observational studies and from randomized controlled 
trials (RCTs) has supported the fact that the epidemic of 
obesity and its comorbidities are the consequences of the 
interaction between multiple gene variants and lifestyle 
factors [8]. A recent review reported that the fat mass and 
obesity-related (FTO) and beta-2 adrenergic receptor 
(ADRB2) genes were the most investigated genes for 
gene-lifestyle interaction studies in intervention pro-
grams [9]. Grau et al. [10] reported that individuals car-
rying the TT genotype of FTO rs9939609 had greater re-
duction in homeostatic model assessment of insulin re-
sistance and homeostatic model assessment beta after 10 
weeks of low-fat diet compared to a high-fat diet in a Eu-
ropean population. However, Matsuo et al. [11] found 
no significant association between FTO rs9939609 and 
weight loss outcomes after 14 weeks of calorie-restricted 
dietary intervention in obese Japanese women. With re-
spect to ADRB2 gene, Ruiz et al. [12] reported that both 
genotypes of ADRB2 rs1042713 (G>A) showed a similar 
reduction in body weight, but that obese Spanish women 
carrying the risk allele (G) of ADRB2 rs1042714 showed 
greater reduction in body weight compared to noncarri-
ers (CC) after 3 months of energy-restricted diet. Low-fat 
dietary intervention was associated with more weight loss 
among overweight and obese individuals with the IRS1 
rs2943641 CC genotype compared to noncarriers (CT 
and TT genotypes) [13]. Overweight and obese individu-
als carrying the T allele of PPM1K rs1440581 lost more 
weight with a low-carbohydrate diet compared to non-
carriers (C allele) [14]. The above is evidence for the fact 
that individuals with different genetic background may 
respond differently to the same intervention program 
[15]. Greater understanding of potential nutrient-gene 
interaction can aid in manipulating diet in a way that 
minimizes the metabolic consequences of obesity, attenu-
ates insulin resistance, and reduces the risk of cardiomet-
abolic diseases [16]. Early identification of at-risk indi-
viduals is of paramount importance. Considering the 
long asymptomatic period preceding the manifestation of 
T2DM and cardiovascular disease, early diagnosis of at-
risk individuals could enable targeted interventions ear-
lier in life, thus reducing morbidity and mortality [17].
Interindividual differences in phenotypes in response 
to dietary interventions highlight the role of nutrigenetics 
in the identification of nutrient-sensitive genotypes [18]. 
Early identification of the candidate gene variants that 
have the potential to influence dietary nutrients metabol-
ically and/or at the molecular level may allow for the pro-
vision of good-quality personalized recommendations of 
nutrient intake to achieve effective weight loss [19].
Recent evidence suggests that the use of polygenic risk 
scores (PRS), including multiple gene variants that pre-
dispose an individual to obesity, may predict the degree 
of risk for obesity and strategically contribute to weight 
management programs [20]. The PRS summarizes the ef-
fect of multiple gene variants into a single score to mea-
sure the genetic susceptibility to a disease [21, 22]. It is 
calculated by summing all the risk alleles of the selected 
gene variants, each allele being weighted by the corre-
sponding effect size [23, 24]. Single nucleotide polymor-
phism (SNP) analyses are often underpowered due to the 
small effect size of individual SNPs. Moreover, overad-
justment for multiple comparisons when testing multiple 
independent SNPs for associations between variables 
may increase the likelihood of type II errors (the chance 
that the effective treatment is not discovered) [25]. Previ-
ous studies have reported that the inclusion of a large 
number of SNPs into PRS models had a larger effect size 
and hence greater predictive power of risk [26].
The aim of this study was to investigate the combined 
effect of FTO rs9930501, rs9930506, and rs9932754 and 
ADRB2 rs1042713 and rs1042714 by PRS on (1) the odds 
of obesity and (2) the post-intervention differences in di-
etary, anthropometric, and cardiometabolic parameters 
in response to a 6-month high-protein calorie-restricted, 
high-vitamin E, high-fiber (Hipcref) diet. The details of 
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the dietary intervention are described in Study Design. To 
the best of our knowledge, this is the first study that com-
puted PRS to investigate the effect of multiple gene vari-
ants on weight loss outcomes in the Malaysian popula-
tion.
Materials and Methods
Study Design
Two different studies were conducted to test the aforemen-
tioned objective: (1) a cross-sectional study (n = 178) to assess the 
effect of PRS on the odds of obesity, and (2) a 6-month RCT (n = 
128) to assess the effect of PRS on the post-intervention differ-
ences in dietary, anthropometric, and cardiometabolic parameters 
in response to a 6-month dietary intervention in overweight and 
obese Malaysian adults [27]. Both studies were nested in the parent 
study which aimed to investigate the gene-diet interaction on obe-
sity-related phenotypes [27–29].
Participant Selection
Cross-Sectional Study. A cross-sectional study was conducted 
to assess the combined effect of FTO (rs9930501, rs9930506, and 
rs9932754) and ADRB2 (rs1042713 and rs1042714) gene variants 
on the odds of obesity using PRS. A total of 178 Malaysian adults 
(Malaysian Chinese, Malays, and Indians) aged ≥18 years were 
recruited at random through advertisements and flyers distributed 
at the University of Nottingham Malaysia campus, supermarkets, 
and schools in the vicinity of the University of Nottingham Malay-
sia. A structured questionnaire was used to record information on 
race and ethnicity, and the questions were directed to trace back 
three generations to confirm ancestry. Participants completed a 
health and lifestyle questionnaire which included questions on 
past diseases, family history of past diseases, physical activity level, 
and substance abuse. Smoking status and alcohol consumption 
were reported as (1) never, (2) former, and (3) current. Individuals 
diagnosed with cardiovascular diseases, stroke, diabetes, renal dis-
orders, or endocrine disorders such as hypothyroidism were ex-
cluded from the study. Exclusion criteria also included pregnant 
woman as well as those on cholesterol-lowering, hypoglycemic, or 
psychiatric medication. Interested individuals attended an initial 
screening to determine whether or not the participants met the 
specified inclusion and exclusion criteria. In total 79 obese and 99 
nonobese Malaysian adults were recruited. Anthropometric pa-
rameters, physical activity levels, substance abuse, blood biochem-
ical parameters, and genotyping for the variants of FTO and 
ADRB2 genes were assessed in the study participants. Detailed in-
formation on the methodology undertaken for the above has been 
described in our earlier publications [28, 29].
RCT – Dietary Intervention. Detailed information on the study 
design and methodology of the Hipcref dietary intervention in 
overweight and obese Malaysian adults has been previously de-
scribed in an earlier publication [27]. Briefly, a 6-month parallel-
arm RCT (Hipcref dietary intervention) was conducted to assess 
the effect of the Hipcref diet on dietary, anthropometric, and car-
diometabolic parameters in the study participants compared to a 
control diet. Participants from the Hipcref diet group received for-
mulated diet charts with an energy deficit of 300–500 kcal/day, 
30% energy from protein, 30% energy from fat, 40% energy from 
carbohydrate, vitamin E ≥15 mg/day, and fiber ≥25 g/day. The 
control diet group received generalized dietary advice on weight 
loss based on the Malaysian Dietary Guidelines 2010 (< 1,500 kcal/
day with a macronutrient composition of approximately 10–15% 
energy from protein, 20–30% energy from fat, and 55–70% energy 
from carbohydrate) [30]. The justification for this dietary strategy 
is based on the results that were generated from the cross-section-
al study [28]. The results revealed that individuals carrying the risk 
allele of FTO rs9930506 had significantly lower high-sensitivity C-
reactive protein (hsCRP) levels with high intake of protein and 
vitamin E compared to low intake of protein and vitamin E [28]. 
Dietary fiber has been reported to have a favorable effect on meta-
bolic profile post-intervention [31]. Therefore, a Hipcref diet was 
formulated for all participants in the intervention arm of the study 
[27]. A total of 128 eligible, apparently healthy overweight and 
obese Malaysian adults (Malaysian Chinese, Malays, and Indians) 
aged ≥18 years with a BMI ≥23 were recruited to participate in the 
Hipcref dietary intervention study. The six waves of recruitment 
(cohorts) had staggered start dates between June 2015 and June 
2018. Participants were randomly assigned to one of the two treat-
ments: intervention diet (Hipcref diet, n = 65) or control diet 
 (control diet, n = 63) using a covariate adaptive randomization 
technique. Eligible participants were stratified by two covariates: 
(1) sex (female and male) and (2) ethnicity (Malaysian Chinese, 
Malays, and Indians), hence a total of 6 (2 × 3) strata were con-
structed. All participants were blinded to the allocation of the di-
etary arm of the study. Of the initial 128 participants, 7 dropped 
out from the Hipcref diet group and 18 dropped out from the con-
trol diet group due to job relocation (n = 9), retirement (n = 5), 
accident (n = 2), volunteer withdrawal of consent (n = 5), and loss 
to follow-up (n = 4). Therefore, the study was completed with 103 
participants: Hipcref diet group = 58 participants (47, females, 11 
males); control diet group = 45 participants (41 females, 4 males).
Assessment on Dietary Intake, Physical Activity, Substance 
Abuse, Dietary Adherence, Anthropometric Parameters, 
Cardiometabolic Parameters, and Genotyping
At baseline and month 6 of the dietary intervention period, the 
following parameters were assessed, measured, and analyzed: di-
etary, anthropometric, physical activity levels, substance abuse, 
biochemical variables in blood, dietary adherence score, and geno-
typing for the variants of FTO and ADRB2 genes. Please refer to 
our earlier publications for the details of the methodology under-
taken for the above [27–29].
Computation of PRS
PRS were calculated as the weighted sum of the risk alleles (FTO 
and ADRB2 genes) possessed by each individual, by computing the 
product of individual risk alleles and their respective natural log of 
odds ratio (OR) for obesity [28, 29]. The formula to evaluate PRS 
is as follows [23, 24, 32]:
1
n
i i
i
PRS WX
=
=å  
where Xi represents the number of risk alleles, Wi represents the 
natural log of the OR of obesity associated with the respective risk 
allele of the SNP, and n represents the number of the SNPs includ-
ed in PRS. All of the five SNPs (FTO rs9930501, rs9930506, and 
rs9932754 and ADRB2 rs1042713 and rs1042714) were included 
in the PRS model. The risk alleles of each SNP were captured from 
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published GWAS studies: FTO rs9930501 (G allele), rs9930506 (G 
allele), and rs9932754 (C allele) and ADRB2 rs1042713 (G allele) 
and rs1042714 (G allele) [33–36]. The odds of obesity for each SNP 
were computed in our earlier studies [28, 29]. Logistic regression 
was conducted to determine the risk of obesity associated with 
gene variants. ORs with 95% CIs were estimated for each genotype. 
These data were substituted in the PRS formula (Table 1). Partici-
pants were then stratified into three equal groups as the first tertile 
(tertile 1, PRS 0–0.64), second tertile (tertile 2, PRS 0.65–3.59), and 
third tertile (tertile 3, PRS 3.60–8.18) of PRS with scores increasing 
from the first to the third tertile.
Power and Sample Size Calculation
In the Hipcref dietary intervention study [27], the sample size 
was computed using the formula n = [2SD2(Z1 – α/2 + Z1 – β)2]/d2, 
according to Charan and Biswas [37]. The primary outcome mea-
sure was the change in body weight. Assuming an expectation of 
10% reduction in body weight, an effect size (d) of 7.6 (76.0 kg – 
68.4 kg = 7.6 kg) with a standard deviation of 11.2 [38] was calcu-
lated. To detect this difference with a significance level of 5% (i.e., 
Z_{1 – alpha/2} = 1.96) and power of 80% (i.e., Z_{1 – β} = 0.84), 
34 participants were required in each group. Assuming an attrition 
rate of 20%, a total of 41 participants were required in each arm of 
the study.
Data Analysis
Statistical analysis was performed using the Statistical Package 
for the Social Sciences version 22 (IBM, Chicago, IL, USA). Data 
were expressed as mean ± standard error or number (percentage). 
Log transformation was performed to transform nonnormally dis-
tributed data into normally distributed data. Participants were 
then stratified into three equal groups as the first tertile (tertile 1, 
PRS 0–0.64), second tertile (tertile 2, PRS 0.65–3.59), and third 
tertile (tertile 3, PRS 3.60–8.18) of PRS with scores increasing from 
the first to the third tertile. In the cross-sectional study, to study 
the effect of PRS on the odds of obesity, data were dichotomized 
into obese and nonobese groups (obesity was defined as a BMI 
≥27.5 according to the WHO for Asian populations) [39]. The first 
tertile of PRS was used as the reference group. OR with 95% CI was 
estimated by logistic regression to determine the odds of obesity 
associated with PRS after adjusting for the covariates age, sex, 
physical activity status, smoking status, and alcohol consumption. 
One-way ANCOVA was performed to assess the differences in the 
continuous variables between the tertiles of PRS. Adjustments on 
the covariates age, sex, physical activity, smoking status, alcohol 
consumption, BMI, and total energy intake were applied where 
appropriate. χ2 test was performed to compute the differences in 
categorical variables between the tertiles of PRS.
With respect to the RCT (Hipcref dietary intervention), the 
study was designed to test an approach applicable to primary care. 
Therefore, the analysis was conducted on an intention-to-treat ba-
sis rather than on compliance to treatment (per protocol), mean-
ing all the participants who had been randomized into the two diet 
groups were included for analysis regardless of noncompleters. For 
the noncompleters, the last observations/measurements on the an-
thropometric, blood biochemical, and dietary parameters were 
carried forward as the post-intervention measurements for analy-
sis. One-way ANCOVA was performed to assess the differences in 
the continuous variables at baseline between the tertiles of PRS 
after adjusting for the covariates age, sex, physical activity status, 
alcohol consumption, smoking status, and BMI. χ2 test was per-
formed to assess the differences in categorical variables at baseline 
between the tertiles of PRS.
The effects of PRS and dietary intervention on the post-inter-
vention differences in anthropometric and cardiometabolic pa-
rameters at month 6 were analyzed using a general linear regres-
sion model, with adjustments for covariates and the baseline value 
for the respective variables. To analyze the potential interactions 
between PRS and dietary intervention on the post-intervention 
differences in anthropometric and cardiometabolic parameters, an 
interaction product term of PRS × dietary group was included in 
the models. A statistical probability level of p < 0.05 (two-sided) 
was considered significant.
Results
Association between PRS and Odds of Obesity
In the cross-sectional study, a total of 178 Malaysian 
adults were recruited for anthropometric measurement 
and genetic analysis (Chinese n = 42 [37 females, 5 males]; 
Malays n = 86 [78 females, 8 males); Indians n = 50 [39 
females, 11 males]). Logistic regression was performed to 
examine the effect of PRS on the odds of obesity (obesity 
was defined as a BMI ≥27.5) [39]. Our result revealed that 
the third tertile of PRS (PRS 3.59–8.18) was associated 
with significantly higher odds of obesity (2.10 [95% CI = 
1.05–4.21, p = 0.036] compared to the first tertile of PRS 
[PRS 0–0.64]) (Table 2). After adjusting for the covariates 
age, sex, physical activity status, alcohol consumption, 
and smoking status, the odds of obesity in the third tertile 
of PRS were increased to 2.29 (95% CI = 1.11–4.72, ad-
justed p = 0.025) compared to the first tertile of PRS. 
However, we found no significant association between 
the second tertile of PRS and the odds of obesity (2.06 
[95% CI = 0.88–4.85, p = 0.096] compared to the first ter-
tile of PRS).
Table 1. Odds of obesity associated with gene variants
Gene SNP Risk 
allele
RAF OR (95% CI) Natural 
log(OR)
FTO rs9930506 [17] G 0.37 2.87 (1.14–7.19) 1.05
rs9930501a G 0.37 3.03 (1.23–7.49) 1.11
rs9932754a C 0.37 3.04 (1.22–7.59) 1.11
ADRB2 rs1042713 [18] G 0.13 1.38 (0.08–23.93) 0.32
rs1042714a G 0.51 1.00 (0.40–2.23) 0
OR, odds ratio; RAF, risk allele frequency; SNP, single nucleo-
tide polymorphism. a Unpublished data.
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General Characteristics: Differences between the 
Tertiles of PRS at Baseline
In the RCT (Hipcref dietary intervention), statistical 
analyses on the comparisons of the general characteristics 
between the tertiles of PRS at baseline were conducted 
(Table 3). Our results revealed that the first tertile of PRS 
had significantly lower waist circumference (WC) (p = 
0.023), fat mass (p = 0.049), and percent body fat (p = 
0.043) compared to the second tertile of PRS. With re-
spect to cardiometabolic parameters, the first tertile of 
PRS had significantly lower hsCRP levels compared to the 
second and third tertiles (p = 0.005). No significant dif-
ference was found between the PRS in dietary parameters 
(p > 0.05) (Table 3). No significant difference was found 
at baseline in other parameters listed in Table 3 between 
the tertiles of PRS.
Moreover, there were significant differences in the dis-
tribution of the tertiles of PRS between the ethnic groups. 
Results from the current study revealed that Indians (3.9 ± 
0.3) had significantly higher PRS compared to Chinese (2.1 
± 0.4) (p = 0.008) after adjusting for covariates (Table 4). 
This finding suggests that Indians were more likely to be 
genetically predisposed to obesity compared to Chinese. 
Dietary Adherence Score: Difference between the 
Tertiles of PRS
No significant difference was found in the adherence 
score between the tertiles of PRS after adjusting for co-
variates (p = 0.501) (Table 5).
Effect of the Interaction between PRS and Dietary 
Group on the Post-Intervention Differences in Dietary 
Parameters
General linear regression analysis revealed no signifi-
cant effect of interaction between PRS and dietary group 
on the post-intervention differences in dietary parame-
ters, even after adjusting for covariates and the baseline 
value for respective variables (p > 0.05) (Table 6).
Effect of the Interaction between PRS and Dietary 
Group on the Post-Intervention Differences in 
Anthropometric and Cardiometabolic Parameters
General linear regression analysis revealed no signifi-
cant effect of interaction between PRS and dietary group 
on the post-intervention differences in body weight and 
obesity-related anthropometric parameters (e.g., BMI, 
Table 2. Association of PRS with the odds of obesity: cross-sectional study (n = 178)
PRS Obese, 
BMI ≥27.5 
(n = 79)
Nonobese, 
BMI <27.5 
(n = 99)
Unadjusted OR 
(95% CI)
Unadjusted 
p value
Adjusted OR 
(95% CI)a
Adjusted 
p valuea
First tertile (PRS 0–0.64) 20 (32.8%) 41 (67.2%) 1 0.082 1 0.067
Second tertile (PRS 0.65–3.58) 20 (50.0%) 20 (50.0%) 2.05 (0.94–4.65) 0.086 2.06 (0.88–4.85) 0.096
Third tertile (PRS 3.59–8.18) 40 (50.6%) 39 (49.4%) 2.10 (1.05–4.21) 0.036* 2.29 (1.11–4.72) 0.025*
Logistic regression was performed to determine the risk of obesity associated with PRS. The first tertile of PRS was used as the 
reference group. ORs with 95% CIs were estimated for each tertile. The average BMIs of the nonobese and obese groups were 23.0 ± 0.3 
and 32.0 ± 0.5, respectively. BMI, body mass index; OR, odds ratio; PRS, polygenic risk score. a Adjusted for age, sex, physical activity 
status, smoking status, and alcohol consumption. * p < 0.05 was considered significant.
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Table 3. General characteristics: differences between the tertiles of PRS at baseline – dietary intervention study in overweight and obese 
individuals (n = 128)
Variable Tertile 1 (n = 38) Tertile 2 (n = 47) Tertile 3 (n = 43) p value
Age, years 42.7±1.7 45.3±1.7 43.7±1.6 0.716
Sex1
Female 33 (86.8%) 39 (83.0%) 36 (83.7%) 0.879 
Male 5 (213.2%) 8 (17.0%) 7 (16.3%)
Ethnicity1
Malays 20 (52.6%) 19 (40.4%) 18 (41.9%) 0.016*
Chinese 12 (31.6%) 7 (14.9%) 5 (11.6%)
Indians 6 (15.8%) 21 (44.7%) 20 (46.5%)
Physical activity status1
Physically inactive 36 (94.7%) 45 (95.7%) 40 (93.0%) 0.850 
Physically active 2 (5.3%) 2 (94.3%) 3 (7.0%)
Smoking status1
Never 37 (97.4%) 45 (95.8%) 43 (100%) 0.590 
Current 0 1 (2.1%) 0
Former 1 (2.6%) 1 (2.1%) 0 
Alcohol consumption1
Never 37 (97.4%) 46 (97.9%) 43 (100%) 0.392
Current 0 1 (2.1%) 0
Former 1 (2.6%) 0 0
Anthropometric parameters
Height2, cm 157.6±1.2 158.7±1.1 157.5±1.1 0.494
Weight2, kg 70.6±1.8 75.9±2.4 74.7±2.8 0.195
BMI2 28.5±0.7 29.9±0.7 30.0±0.8 0.233
WC2, cm 89.4±1.6a 96.4±1.8b 94.9±2.0 0.023*
WHR2 0.90±0.01 0.93±0.01 0.92±0.01 0.050
Muscle mass2, kg 23.0±07 23.8±0.8 23.4±0.8 0.861
Fat mass2, kg 28.5±1.3a 32.6±1.5b 31.7±1.8 0.049*
Fat-free mass2, kg 42.0±1.2 43.3±1.3 43.0±1.3 0.877
Body fat2, % 40.1±1.1a 42.6±0.9b 42.6±0.9 0.043*
Systolic blood pressure2, mm Hg 120.6±2.3 125.2±2.4 121.9±2.1 0.394
Diastolic blood pressure2, mm Hg 79.5±1.6 81.1±1.4 81.9±1.7 0.556
Pulse rate2, bpm 75.8±2.1 76.4±1.6 77.2±1.5 0.791
Blood biochemical parameters
Fasting glucose3, mmol/L 4.9±0.1 5.2±0.2 5.6±0.4 0.172
Fasting insulin3, μU/mL 8.6±1.3 10.2±1.4 11.4±1.7 0.775
HOMA-IR3 1.9±0.3 2.6±0.6 2.9±0.5 0.549
TC3, mmol/L 5.6±0.2 5.3±0.2 5.7±0.2 0.170
Triglyceride3, mmol/L 1.3±0.1 1.4±0.1 1.4±0.1 0.565
HDL-C3, mmol/L 1.7±0.1 1.5±0.04 1.5±0.1 0.050
LDL-C3, mmol/L 3.4±0.1 3.2±0.1 3.5±0.2 0.310
TC/HDL-C3 3.5±0.2 3.7±0.1 4.0±0.2 0.127
hsCRP3, mg/L 2.9±0.6a 6.6±1.1b 7.3±1.6b 0.005*
Dietary parameters
TE4, kcal 1,945±45 2,028±47 2,034±63 0.609
Protein intake4, g 75.2±3.0 72.3±3.2 74.3±4.0 0.334
Fat intake4, g 78.9±2.9 82.9±3.3 86.2±3.4 0.473
Carbohydrate intake4, g 243.4±10.6 259.1±8.9 257.0±10.5 0.807
Energy from protein3, % 15.5±0.7 14.2±0.6 14.3±0.6 0.274
Energy from fat4, % 36.6±1.1 36.1±1.1 37.6±1.0 0.430
Energy from carbohydrate4, % 46.7±1.3 47.6±1.4 46.9±1.2 0.981
Saturated fatty acids4, % of TE 7.8±0.6 7.3±0.5 8.3±0.7 0.812
Monounsaturated fatty acids4, % of TE 11.7±0.7 10.7±0.6 11.2±0.7 0.557
Polyunsaturated fatty acids4, % of TE 6.7±0.5 6.3±0.5 6.4±0.5 0.566
Trans fatty acids4, % of TE 0.1±0.02 0.1±0.04 0.1±0.02 0.687
Energy-adjusted fiber intake4, g 5.8±0.4 6.0±0.6 5.8±0.5 0.915
Energy-adjusted vitamin E intake4, mg 6.3±0.4 5.8±0.5 5.4±0.5 0.098
Data are expressed as mean ± standard error or n (%). Tertile 1: PRS 0–0.64; tertile 2: PRS 0.65–3.58; tertile 3: PRS 3.59–8.18. BMI, body mass index; HDL-C, 
high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin resistance; hsCRP, high-sensitivity C-reactive protein; LDL-C, low-
density lipoprotein cholesterol; PRS, polygenic risk score; TC, total cholesterol; TE, total energy intake; WC, waist circumference; WHR, waist-hip ratio. 
1 p value based on χ2 test. 2–4 p value based on ANCOVA, after adjusting for covariates in different models: 2 age, sex, physical activity, smoking status, and alcohol 
consumption; 3 model2 + BMI; 4 model2 + TE. a, b Figures not sharing a common letter are significantly different at p < 0.05. * p < 0.05 was considered significant.
Tan/MitraLifestyle Genomics 2020;13:84–9890
DOI: 10.1159/000505662
WC, waist-hip ratio, fat mass, percent body fat, and mus-
cle mass) at month 6 of the dietary intervention, in over-
weight and obese Malaysian adults (p > 0.05), after adjust-
ing for covariates and the baseline value for respective 
variables (Table 7). However, with respect to cardiometa-
bolic parameters our results revealed a significant effect 
in the interaction between PRS and dietary group on the 
post-intervention differences in hsCRP levels (p interac-
tion = 0.048) after adjusting for the covariates and the 
baseline value for hsCRP. Participants from the second 
tertile of PRS had significantly greater reduction in hsCRP 
level with the Hipcref diet compared to the control diet 
(–2.5 ± 0.9 vs. –0.03 ± 0.6 mg/L, p = 0.025) after the inter-
vention (Fig. 1). Similarly, participants from the third ter-
tile of PRS had significantly greater reduction in hsCRP 
level with the Hipcref diet compared to the control diet 
(–2.4 ± 1.0 vs. –0.8 ± 0.8 mg/L, p = 0.025) after the inter-
vention period (Fig. 1).
Discussion
Polygenic risk scoring accounts for the combined effect 
of multiple SNPs on disease outcomes and may have a 
larger combined effect size and hence higher power to de-
tect association with diseases than an individual SNP [40]. 
Therefore, quantitative measurement of the effect of mul-
tiple gene variants is essential to detect the modulatory 
effect of gene variants on weight loss outcomes. In this 
study we aimed to compute PRS to investigate the com-
bined effect of FTO rs9930501, rs9930506, and rs9932754 
and ADRB2 rs1042713 and rs1042714 gene variants on 
(1) the odds of obesity, dietary intake, anthropometric pa-
rameters, and cardiometabolic parameters and (2) the 
post-intervention differences in dietary intake, anthropo-
metric parameters, and cardiometabolic parameters in re-
sponse to a 6-month dietary intervention (Hipcref diet).
Association between PRS and the Odds of Obesity
Data from the cross-sectional study revealed that indi-
viduals from the third tertile of PRS (PRS 3.60–8.18) were 
associated with increased odds of obesity compared to the 
first tertile of PRS (PRS 0–0.64). This finding suggests that 
individuals carrying higher PRS were associated with in-
creased odds of obesity compared to individuals carrying 
lower PRS. The current study highlights that the PRS pro-
vides a measure of genetic predisposition to obesity. Ear-
ly screening of the candidate gene variants of FTO and 
ADRB2 genes may identify individuals at risk of obesity 
[41].
Association between PRS and Anthropometric, 
Cardiometabolic, and Dietary Intake Parameters at 
Baseline
Data from the cross-sectional study revealed no sig-
nificant differences at baseline in dietary intake between 
the tertiles of PRS. WC, fat mass, and percent body fat 
were significantly higher in the second compared to the 
first tertile. The scores in the third tertile were higher, but 
did not reach statistical significance due to a smaller 
number of individuals categorized in the third tertile 
(second tertile n = 47; third tertile n = 43). With respect 
to cardiometabolic parameters, the second and third ter-
tiles of PRS had significantly higher hsCRP levels com-
pared to the first tertile. The current study shows that 
higher PRS were associated with increased WC, fat mass, 
percent body fat, and hsCRP levels compared to lower 
PRS.
PRS and Ethnicity
This study reports that with respect to FTO and ADRB2 
genes and their respective gene variants, significant dif-
ferences exist between the three major Malaysian ethnic 
Table 4. Differences between the ethnic groups in the mean ± stan-
dard error values of PRS
Ethnicity PRS p value
Chinese (n = 24) 2.1±0.4* 0.008*
Malays (n = 57) 3.0±0.4 –
Indians (n = 47) 3.9±0.3* –
PRS, polygenic risk score. * p < 0.05 was considered significant 
based on ANCOVA after adjusting for the covariates age, sex, 
physical activity, smoking status, and alcohol consumption.
Table 5. Dietary adherence scores: differences between the tertiles 
of PRS
Adherence score Tertile 1 
(n = 38)
Tertile 2 
(n = 47)
Tertile 3 
(n = 43)
p 
value
Mean ± SE 5.8±0.8 6.6±0.9 5.5±0.7 0.501
Minimum 4.1 4.9 4.1 –
Maximum 7.4 8.4 6.8 –
Tertile 1: PRS 0–0.64; tertile 2: PRS 0.65–3.58; tertile 3: PRS 
3.59–8.18. PRS, polygenic risk score; SE, standard error. p < 0.05 
was considered significant based on ANCOVA after adjusting for 
the covariates age, sex, physical activity, smoking status, and 
alcohol consumption.
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Table 6. Effect of the interaction between PRS and dietary group on the post-intervention differences in dietary parameters in response 
to the 6-month Hipcref diet or the control diet
Dietary parameter Group Hipcref diet group (n = 65) Control diet group (n = 63) p interaction 
(PRS × 
intervention 
group)a
tertile 1 
(n = 20)
tertile 2 
(n = 22)
tertile 3 
(n = 23)
tertile 1 
(n = 18)
tertile 2 
(n = 25)
tertile 3 
(n = 20)
TE, kcal baseline 2,003±72 2,017±74 2,041±96 1,904±50 2,038±62 2,025±81 0.185
month 6 1,629±58 1,618±54 1,556±49 1,880±64 1,988±63 2,010±60
change –374±66 –400±61 –485±68 –25±39 –50±25 –15±30
Protein intake, g baseline 80.4±6.0 70.6±4.0 76.0±5.7 76.4±4.3 73.8±5.0 72.3±5.6 0.962
month 6 111.1±4.8 105.9±5.5 107.3±4.2 73.4±3.0 76.9±4.4 76.4±3.2
change 30.7±7.7 35.4±5.4 31.4±4.7 –3.0±4.6 3.1±3.4 3.0±4.3 
Fat intake, g baseline 81.2±4.5 85.8±4.8 86.6±5.1 76.1±3.0 80.4±4.5 80.8±2.5 0.293
month 6 58.0±3.2 59.5±3.7 55.5±2.2 70.7±4.1 75.1±3.8 79.3±4.4
change –23.2±4.5 –26.3±4.8 –31.2±4.9 –5.4±3.2 –5.4±3.5 –6.3±2.9
Carbohydrate baseline 245.4±17.5 252.6±12.3 256.9±15.8 241.2±10.2 264.8±12.8 257.2±14.0 0.926
intake, g month 6 177.2±8.6 176.7±8.8 171.8±7.3 258.9±8.6 271.2±11.1 265.4±10.5
change –68.2±14.2 –76.0±10.7 –85.2±13.9 17.7±9.7 6.4±6.9 8.2±8.6
Energy from baseline 16.1±1.1 13.9±0.7 14.5±0.7 15.9±1.1 14.6±0.9 14.1±0.9 0.596
protein, % month 6 27.5±0.9 26.6±1.3 27.6±0.6 15.4±0.3 15.5±0.7 15.0±0.4
change 11.4±1.4 12.7±1.4 13.0±1.1 –0.6±1.0 0.9±0.7 0.9±0.8
Energy from fat, % baseline 37.0±1.9 37.4±1.5 37.7±1.5 35.6±1.0 35.0±1.7 37.6±1.4 0.555
month 6 31.4±1.0 33.1±1.4 32.3±1.0 37.7±2.0 37.7±1.8 37.3±1.8
change –5.0±1.7 –4.6±1.3 –2.9±1.0 –2.0±1.1 –1.5±1.4 –2.2±1.2
Energy from baseline 45.8±2.1 46.0±2.1 46.7±1.7 47.1±1.2 49.0±1.8 47.2±1.8 0.496
carbohydrate, % month 6 43.7±0.9 42.8±1.1 43.5±1.0 50.5±2.8 49.5±2.6 50.2±2.1
change –2.7±1.7 –3.0±2.0 –3.0±1.7 75±1.8 4.7±1.6 5.0±1.6
Saturated fatty acids, baseline 7.8±0.8 8.5±0.7 8.0±0.7 8.0±0.8 6.2±0.5 8.7±1.1 0.935
% of TE month 6 7.6±0.5 8.4±0.6 8.5±0.6 8.4±0.8 8.7±0.7 9.9±0.7
change –0.2±0.8 –0.1±0.7 0.5±1.1 0.4±0.9 2.6±0.6 1.1±1.0
Monounsaturated baseline 12.2±1.0 11.8±0.9 10.3±1.0 11.0±0.7 9.8±0.8 12.4±1.0 0.683
fatty acids, % of TE month 6 10.2±0.6 10.9±0.7 10.5±0.5 10.2±05 10.2±0.6 11.6±0.7
change –1.9±0.8 –0.9±0.9 0.2±0.8 –0.9±0.7 0.4±0.8 –0.8±1.2
Polyunsaturated fatty baseline 7.1±0.6 6.9±0.9 5.9±0.8 6.4±0.7 5.7±0.6 6.9±0.7 0.572
acids, % of TE month 6 8.3±0.5 8.2±0.6 7.7±0.5 7.4±0.9 5.9±0.6 6.4±0.4
change 1.2±0.7 1.3±0.7 1.8±0.8 1.0±0.8 0.2±0.6 –0.6±0.7
Trans fatty acids, baseline 0.2±0.03 0.1±0.03 0.1±0.03 0.1±0.03 0.1±0.01 0.1±0.02 0.726
% of TE month 6 0.1±0.02 0.1±0.02 0.1±0.02 0.2±0.03 0.2±0.03 0.2±0.02
change –0.1±0.04 –0.02±0.03 –0.01±0.03 0.1±0.04 0.03±0.1 0.04±0.03
Energy-adjusted baseline 6.2±0.6 7.0±0.8 5.6±0.7 5.6±0.6 5.0±0.8 6.0±0.7 0.571
fiber intake, g month 6 13.0±0.9 13.7±0.7 13.8±0.8 9.5±0.8 8.0±0.7 9.8±0.8
change 6.8±0.9 6.6±1.0 8.2±0.9 3.9±0.8 3.0±0.8 3.9±0.7
Energy-adjusted baseline 5.8±0.6 6.7±0.9 4.8±0.7 6.9±0.6 5.1±0.5 6.1±0.8 0.761
vitamin E intake, mg month 6 8.0±0.3 8.4±0.5 7.6±0.4 6.8±0.6 5.8±0.4 6.8±0.5
change 2.2±0.7 1.7±0.7 2.9±0.6 –0.9±0.6 0.7±0.5 0.5±0.4
Tertile 1: PRS 0–0.64; tertile 2: PRS 0.65–3.58; tertile 3: PRS 3.59–8.18. Hipcref, high-protein calorie-restricted, high-vitamin E, high-fiber; PRS, poly-
genic risk score; TE, total energy intake. a A general linear regression model was used to assess the effect of the interaction between PRS and dietary group 
on the post-intervention differences in dietary parameters after adjusting for age, sex, physical activity, smoking status, alcohol consumption, TE, and the 
baseline value for the respective variable. 
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Table 7. Effect of the interaction between PRS and dietary group on the post-intervention differences in anthropometric and blood bio-
chemical parameters in response to the 6-month Hipcref diet or the control diet
Group Intervention diet group (n = 65) Control diet group (n = 63) p interaction 
(PRS × 
intervention 
group)a
tertile 1 
(n = 20)
tertile 2 
(n = 22)
tertile 3
(n = 23)
tertile 1 
(n = 18)
tertile 2 
(n = 25)
tertile 3 
(n = 20)
Anthropometric parameters
Weight, kg baseline 72.4±2.9 75.2±3.3 74.9±1.6 68.5±1.9 76.4±3.6 74.5±5.8 0.058
month 6 69.9±3.0 72.1±3.4 70.3±1.9 69.5±1.9 77.6±3.6 76.3±5.7
change –2.5±0.7 –3.2±0.7 –4.6±1.0 1.0±0.6 1.1±0.6 1.8±0.5
BMI baseline 29.3±1.2 29.6±1.1 29.8±0.6 27.6±0.7 30.2±0.9 30.1±1.6 0.125
month 6 28.2±1.2 28.4±1.2 28.0±0.8 28.0±0.8 30.7±1.0 30.9±1.6
change –1.1±0.3 –1.3±0.3 –1.8±0.4 0.4±0.9 0.5±0.3 0.8±0.2
WC, cm baseline 91.1±2.6 94.4±2.7 93.9±2.1 87.5±1.8 98.1±2.4 96.1±3.7 0.224
month 6 85.9±3.0 88.4±3.0 86.7±2.5 88.6±2.1 99.3±2.5 98.2±3.5
change –5.2±1.1 –6.1±1.0 –7.2±1.1 1.1±1.1 1.2±0.6 2.1±0.5
WHR baseline 0.89±0.02 0.92±0.01 0.92±0.01 0.90±0.01 0.94±0.02 0.93±0.01 0.369
month 6 0.89±0.01 0.91±0.01 0.90±0.01 0.90±0.01 0.94±0.02 0.95±0.02
change –0.01±0.01 –0.01±0.01 –0.02±0.01 0.01±0.01 0.01±0.01 0.01±0.01
Muscle mass, baseline 23.6±1.2 24.1±1.2 23.7±0.7 22.2±0.8 23.4±1.1 23.1±1.5 0.068
kg month 6 23.5±1.1 24.0±1.2 23.0±0.6 22.3±0.8 23.3±1.1 23.4±1.5
change –0.1±0.2 –0.1±0.3 –0.8±0.3 0.02±0.4 –0.1±0.2 0.3±0.2
Fat mass, kg baseline 29.4±2.2 31.5±2.0 31.3±1.3 27.6±1.2 33.6±2.1 32.2±3.7 0.234
month 6 27.0±2.4 28.3±2.3 28.2±1.5 28.0±1.4 34.9±2.1 33.6±3.6
change –2.4±0.8 –3.2±0.7 –3.2±0.8 0.4±0.6 1.2±0.5 1.4±0.4
Fat-free mass, baseline 43.4±1.9 43.8±2.0 43.5±1.1 40.9±1.2 42.8±1.8 42.3±2.5 0.069
kg month 6 42.8±1.9 43.9±2.0 41.9±1.1 42.1±1.5 42.7±1.8 42.7±2.5
change –0.3±0.3 0.1±0.6 –1.7±0.6 1.2±0.9 –0.1±0.2 0.4±0.3
Body fat, % baseline 40.0±1.9 41.5±1.4 41.7±1.2 40.2±1.1 43.6±1.0 42.0±1.7 0.468
month 6 37.9±2.1 38.6±1.8 39.7±1.3 40.4±1.4 44.6±1.1 43.0±1.7
change –2.1±0.8 –2.9±0.8 –2.0±0.8 0.2±0.7 1.1±0.4 1.0±0.4
SBP, mm Hg baseline 121.5±3.3 126.5±3.3 123.4±3.0 119.6±3.1 124.0±3.6 120.2±2.8 0.843
month 6 116.6±3.1 121.1±3.5 118.0±2.6 117.6±3.8 122.6±2.9 116.5±3.0
change –5.0±2.6 –5.4±2.3 –5.3±2.7 –2.0±3.2 –1.4±1.8 –3.7±1.9
DBP, mm Hg baseline 81.9±2.5 80.8±2.2 84.3±2.5 76.9±1.9 81.3±1.9 79.3±2.1 0.843
month 6 77.3±2.9 78.1±2.4 78.7±1.9 75.3±2.0 78.9±2.0 76.7±2.5
change –4.6±1.5 –2.8±1.7 –5.5±2.3 –1.6±1.8 –2.4±1.0 –2.6±2.0
Pulse rate, baseline 76.5±3.0 77.7±2.4 77.4±1.9 75.0±3.0 75.3±2.1 76.9±2.4 0.105
bpm month 6 72.9±3.6 74.5±2.6 71.2±2.2 68.9±2.5 71.9±2.2 76.0±2.4
change –3.5±2.7 –3.2±2.3 –6.2±2.2 –6.0±2.4 –3.4±1.9 –0.9±1.5
Blood biochemical parameters
Fasting baseline 5.0±0.3 5.3±0.4 5.1±0.2 4.6±0.1 5.1±0.2 6.2±0.9 0.381
glucose, month 6 5.3±0.3 5.0±0.5 5.2±0.2 4.9±0.2 5.3±0.3 6.0±0.7
mmol/L change 0.2±0.2 –0.4±0.5 0.1±0.2 0.3±0.2 0.3±0.3 –0.2±0.3
Fasting baseline 11.4±2.2 11.5±2.3 12.5±3.0 5.4±0.6 9.0±1.6 10.2±1.5 0.121
insulin, month 6 8.3±1.0 8.3±1.3 8.5±1.1 9.0±1.3 13.2±2.6 15.9±2.0
μU/mL change –3.2±2.1 –3.2±1.3 –4.0±2.6 3.6±1.3 4.1±1.4 5.7±1.7
HOMA-IR baseline 2.6±0.5 3.4±1.1 3.0±0.8 1.1±0.1 1.9±0.3 2.8±0.6 0.122
month 6 1.9±0.3 2.1±0.5 2.0±0.3 2.0±0.3 3.3±0.7 4.4±0.8
change –0.6±0.5 –1.3±0.9 –1.0±0.7 0.9±0.3 1.3±0.5 1.6±0.6
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groups. Malaysian Indians had significantly higher PRS 
compared to Malaysian Chinese. An earlier study report-
ed that Malaysian Indians had a significantly higher fre-
quency of the risk allele (G) of FTO rs9930506 compared 
to Malaysian Chinese and Malays [28]. This finding adds 
to the existing evidence that differences in allele frequen-
cies and gene variants do exist in various ethnic groups. 
This fact should be accounted for when designing inter-
vention programs in multiethnic populations.
PRS and Post-Intervention Differences in Body Weight 
and Body Composition
In the RCT of the current study, it was found that at 
month 6 of the Hipcref dietary intervention, participants 
in the first, second, and third tertiles of PRS lost on average 
2.5, 3.2, and 4.6 kg of body weight, respectively. No weight 
loss was observed in the control group. In the intervention 
group, the difference in weight loss was not statistically sig-
nificant between the PRS tertiles. However, individuals 
with the risk alleles responded to the weight loss program 
positively. Moreover, the data show a positive linear trend 
in the reduction of body weight (–2.5, –3.2, and –4.6 kg), 
BMI (–1.1, –1.3, and –1.8), WC (–5.2, –6.1, and –7.2 cm), 
and fat mass (–2.4, –3.2, and –3.2 kg) across the PRS tertiles 
(first, second, and third, respectively).
FTO. A recent meta-analysis of 9,563 participants in-
volving 8 RCTs reported that the post-intervention dif-
ferences in body weight, WC, and adiposity were not sig-
nificantly different between the risk allele (A) and the 
non-risk allele carriers (T) of FTO rs9939609 [42]. How-
ever, other authors have reported contradictory findings. 
A meta-analysis by Xiang et al. [43] reported that indi-
viduals carrying the risk allele of FTO rs9939609 (TA and 
TT genotypes) lost more weight through diet or lifestyle 
intervention compared to the non-risk allele carriers 
(AA). The authors also reported that in a subgroup anal-
ysis, a stronger effect of FTO rs9939609 on weight loss 
was found in response to calorie-restricted diets com-
Group Intervention diet group (n = 65) Control diet group (n = 63) p interaction 
(PRS × 
intervention 
group)a
tertile 1 
(n = 20)
tertile 2 
(n = 22)
tertile 3
(n = 23)
tertile 1 
(n = 18)
tertile 2 
(n = 25)
tertile 3 
(n = 20)
TC, mmol/L baseline 5.7±0.2 5.3±0.2 5.5±0.2 5.5±0.3 5.3±0.2 5.9±0.3 0.944
month 6 5.5±0.2 5.4±0.2 5.1±0.2 5.4±0.3 5.4±0.2 5.4±0.2
change –0.2±0.1 0.1±0.2 –0.4±0.2 –0.04±0.2 0.1±0.1 –0.5±0.2
Triglyceride, baseline 1.5±0.2 1.5±0.2 1.4±0.2 1.0±0.1 1.3±0.2 1.5±0.2 0.456
mmol/L month 6 1.6±0.2 1.5±0.2 1.4±0.2 1.0±0.1 1.5±0.2 1.5±0.2
change –0.1±0.1 0±0.1 0±0.3 –0.02±0.1 0.1±0.1 0.1±0.1
HDL-C, baseline 1.6±0.1 1.5±0.1 1.5±0.1 1.8±0.1 1.5±0.1 1.4±0.1 0.527
mmol/L month 6 1.4±0.1 1.4±0.1 1.5±0.1 1.6±0.1 1.4±0.1 1.3±0.1
change –0.1±0.1 –0.03±0.1 –0.1±0.1 –0.2±0.1 –0.02±0.03 –0.2±0.04
LDL-C, baseline 3.5±0.2 3.2±0.2 3.3±0.2 3.2±0.2 3.2±0.2 3.8±0.2 0.672
mmol/L month 6 3.4±0.2 3.2±0.2 3.1±0.2 3.4±0.2 3.2±0.2 3.4±0.2
change –0.1±0.1 0±0.2 –0.3±0.2 0.2±0.1 –0.01±0.1 –0.3±0.2
TC/HDL-C baseline 3.8±0.2 3.7±0.2 3.8±0.3 3.1±0.2 3.7±0.2 4.2±0.2 0.055
month 6 4.1±0.3 4.2±0.2 3.7±0.2 3.5±0.2 3.9±0.2 4.4±0.2
change 0.3±0.1 –0.1±0.3 –0.1±0.3 0.4±0.1 0.2±0.1 0.3±0.2
hsCRP, mg/L baseline 3.8±1.0 6.1±1.5 8.3±2.3 1.7±0.3 7.2±1.7 6.2±2.2 0.048*
month 6 3.8±0.9 3.4±0.9 4.9±1.4 2.1±0.6 7.6±1.3 6.6±1.8
change 0.9±1.0 –2.5±0.9 –2.4±1.0 0.3±0.6 –0.03±0.6 0.8±0.8
Tertile 1: PRS 0–0.64; tertile 2: PRS 0.65–3.58; tertile 3: PRS 3.59–8.18. BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density 
lipoprotein cholesterol; Hipcref, high-protein calorie-restricted, high-vitamin E, high-fiber; HOMA-IR, homeostatic model assessment of insulin resistance; 
hsCRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; PRS, polygenic risk score; SBP, systolic blood pressure; TC, total 
cholesterol; WC, waist circumference; WHR, waist-hip ratio. a A general linear regression model was used to assess the effect of the interaction between PRS 
and dietary group on the post-intervention differences in anthropometric and cardiometabolic parameters after adjusting for age, sex, physical activity, 
smoking status, alcohol consumption, and the baseline value for the respective variable. * p < 0.05 was considered significant.
Table 7 (continued)
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pared to other interventions. The current study is in con-
gruence with Xiang et al. [43].
ADRB2. No significant association was found be-
tween ADRB2 gene polymorphisms (rs1042713 and 
rs1042714) and weight loss after 7 weeks of lifestyle mod-
ification [44]. After 3 months of calorie-restricted diet, 
obese Spanish women carrying the risk allele (CG and 
GG genotypes) of ADRB2 rs1042714 had greater reduc-
tion in body weight compared to the non-risk allele car-
riers (CC) [12]. The authors suggest that there may be a 
sex-specific genetic association on the changes in body 
weight between ADRB2 rs1042714 and the intervention 
employed. Due to the smaller sample size of our male 
participants, data were not stratified according to sex for 
further analysis. This limits the power to detect differ-
ences in sex on the gene-diet interaction in the current 
study.
PRS and Post-Intervention Differences in 
Cardiometabolic Parameters
As observed in the current cross-sectional study, 
higher PRS was associated with increased hsCRP levels 
at baseline. In the RCT, significant post-intervention re-
duction in hsCRP levels was revealed in the second and 
third tertiles of PRS (–2.5 mg/L, p = 0.025, and –2.4 mg/L, 
p = 0.025, respectively) compared to the control diet. 
This finding suggests that the Hipcref diet successfully 
attenuated the effect of PRS on hsCRP levels and that 
higher-risk individuals benefited most. Obesity is a 
chronic low-grade inflammatory state that is associated 
with increased risk of MetS, diabetes, and cardiovascular 
disease [45]. hsCRP is a common systemic marker for 
investigation of inflammation and also an independent 
predictor of future cardiovascular events [46]. Previous 
studies have demonstrated the influence of proinflam-
matory cytokine gene variants, including tumor necrosis 
factor alpha (rs1800629) and interleukin 6 (rs1800795 
and rs1800797), on the risk of central obesity, diabetes, 
and MetS [47–49]. The current study did not find any 
significant difference in the other (reported) cardiometa-
bolic parameters. However, the data show a positive lin-
ear trend in the reduction of fasting insulin (–3.2, –3.2, 
and –4.0) and homeostatic model assessment of insulin 
resistance (–0.6, –1.3, and –1.0) across the PRS tertiles 
(first, second, and third, respectively) with dietary inter-
vention (Table 7).
The Look AHEAD study reported that a moderate 
improvement in body weight and fitness after 1 year of 
lifestyle intervention through calorie restriction and 
physical activity was not able to mitigate the unfavorable 
cardiometabolic effects (e.g., hsCRP and triglyceride 
levels) associated with GCKR Leu446Pro in overweight 
and obese individuals with diabetes mellitus [50]. It is 
interesting to note that the average age (± standard de-
viation) of the Look AHEAD study was 59.0 ± 6.8 years 
and that our study participants had an average age (± 
standard error) of 43.7 ± 1.6 years. We opine that the 
advanced age in the Scottish population may have pre-
cipitated the comorbidities in the group with the risk al-
lele. Moreover, our participants were apparently healthy 
overweight and obese adults without any clinical meta-
bolic conditions.
Calorie Restriction, hsCRP, and PRS. In the RCT of the 
current study, the data showed a positive linear trend in 
the reduction of total energy intake (–374, –400, and 
–485 kcal/day) across the tertiles of PRS (first, second, 
and third, respectively). It is common knowledge that an 
increase in hsCRP level is associated with increased adi-
pose tissue [51]. Therefore, a reduction in excess body fat 
stores can significantly reduce the inflammatory state of 
individuals [52]. Reduction of hsCRP levels in individu-
als may be due to the consequence of weight loss follow-
ing a moderate reduction in calorie intake [53]. Further, 
reduction in total energy intake through calorie-restrict-
ed diet resulted in a significant reduction in hsCRP levels 
and the risk of atherosclerosis in various populations [54, 
55]. The current study reveals that individuals with high-
er scores, i.e., at higher risk, had lower energy intake 
through the 6 months of the intervention trial. The 
mechanism underlying our findings is currently unclear. 
Mega et al. [56] reported that genetic risk scoring identi-
fied individuals at increased risk of both incident and 
recurrent coronary heart disease events. Further, indi-
viduals with the highest burden of genetic risk derived 
the largest relative and absolute clinical benefit from 
statin therapy. The authors explained that absolute risk 
reduction can depend on the risk profile of the popula-
tion. In their study, patients with a higher burden of 
SNPs experienced a greater benefit with statin therapy. 
The authors opined that the possible explanation could 
be that more plaques were stabilized with the treatment. 
However, they cautioned that this idea merits further 
study to elucidate the underlying mechanism. In the cur-
rent study, individuals with a higher burden of risk re-
sponded better to calorie restriction. The plausible expla-
nation could be that those with higher burden of risk 
benefited through multiple phenotypes, e.g., reduction 
in body weight, BMI, WC, fat mass, and hsCRP levels. 
These positive effects may have induced a sense of well-
being which then motivated the participants to adhere to 
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the intervention diet, followed by reduction in fat mass 
which resulted in significant reduction in the inflamma-
tory marker as well.
High Protein Intake and PRS. In the RCT section of the 
current study, our data showed a positive linear trend in 
the increase of percent energy from protein (11.4, 12.7, 
and 13.0%) across the tertiles of PRS (first, second, and 
third, respectively). According to Merritt et al. [57], indi-
viduals carrying the risk allele (A) of rs1558902 of the 
FTO gene had higher BMI and WC with lower dietary 
protein intake compared to noncarriers (T). This effect 
was not found in the higher protein intake risk group, 
suggesting that high protein intake may be protective 
against the effect of FTO gene on BMI and WC. In the 
current study, high percent energy from protein (Hipcref 
diet intervention) may have benefited individuals with 
higher PRS. Huang et al. [58] reported that the risk allele 
carriers (A) of FTO rs9930609 had significant reduction 
in food craving and appetite with a hypocaloric high-pro-
tein weight loss diet. FTO is highly expressed in the arcu-
ate nucleus of the hypothalamus. Animal and in vitro 
studies suggest that FTO plays an important role in sens-
ing cellular amino acids [59]. The sensing of amino acid 
levels in the brain is known to mediate orexigenic and 
anorexigenic pathways to control food intake and modu-
late energy balance. Studies have suggested that the avail-
ability of essential amino acids may be one of the factors 
regulating FTO levels. FTO mRNA and protein levels 
were found to be dramatically downregulated by total 
amino acid deprivation [60]. Therefore, it is suggested 
that the participants with the highest PRS benefited most 
with high protein intake through the Hipcref diet. How-
ever, the mechanism for this effect is not clear at present. 
As to the ADRB2 gene, a study by Fernandez-Twinn et al. 
[61] reported that rodent offspring on a “low-protein 
diet” demonstrated reduced beta-adrenergic responsive-
ness and attenuated adrenergic and insulin signaling, 
which increased the risk of heart failure and insulin resis-
tance in the animals. This finding corroborates with the 
current findings as well.
Vitamin E, hsCRP, and PRS. In the RCT section of the 
current study, the data showed a positive linear trend 
in the intake of energy-adjusted vitamin E (2.2, 1.7, and 
2.9 mg) between the first and last tertile of PRS. Vitamin 
E is a micronutrient with antioxidant and immune-
modulating properties which can reduce oxidative stress 
and influence inflammatory processes [62]. A signifi-
cant inverse association of vitamin E and hsCRP has 
been demonstrated in some studies [63, 64]. The authors 
reported that vitamin E may have modulated the expres-
sion of the FTO gene through deactivation of PKC sig-
naling, which in turn attenuated weight gain. Moreover, 
Qin et al. [65] also reported that combined treatment 
with vitamins C and E resulted in diminished oxidative 
stress and prevented the loss of beta-adrenergic receptor 
activity due to overstimulation in rabbits with myocar-
dial infarction.
Polyunsaturated Fatty Acids (PUFAs) and PRS. The 
current study reveals a positive linear trend in the intake 
of PUFAs (percent energy of total energy intake) (1.2, 1.3, 
and 1.8%), across the PRS tertiles (first, second, and third, 
respectively) (Table 6). Cell and animal studies have dem-
onstrated beneficial effects of long-chain n-3 PUFAs on 
inflammation and insulin sensitivity [66–68]. The PPARγ 
Pro12Ala polymorphism (rs1801282) is an example of 
the relevance of gene-nutrient interactions in the devel-
opment of obesity, MetS, and T2DM. As the ratio of total 
PUFAs to saturated fatty acids increased, a significant in-
verse relationship was shown for both fasting insulin con-
centrations and BMI in the Ala (G allele) carriers, sug-
gesting that the potential protective effect of the Ala allele 
may be lost in the presence of a high saturated fatty acid 
diet [69]. More recently an inverse relationship between 
Ala frequency and prevalence of T2DM prevalence was 
observed in populations where energy from lipids ex-
ceeded 30% of the total energy intake [70]. The current 
study reports that study participants with risk alleles of 
FTO and ADRB2 and possessing higher PRS benefited 
most from increased PUFA and vitamin E intake through 
the Hipcref diet intervention.
High Fiber Intake and PRS. Hosseini-Esfahani et al. 
[71] suggested that dietary fiber may modify the associa-
tion of FTO SNPs (using genetic risk score) and obesity. 
The authors reported that in a Middle Eastern popula-
tion, individuals with a high genetic risk score and high 
fiber intake had the lowest risk of obesity compared to 
those with a low genetic risk score and low fiber intake. 
Moreover, individuals carrying the AA genotype of FTO 
rs11076023 in the third tertile of dietary fiber intake had 
significantly lower WC compared to noncarriers (AT and 
TT genotypes) [72]. In the RCT section of the current 
study, the dietary data showed a positive linear trend in 
fiber intake (6.8, 6.6, and 8.2 g) between the first and last 
tertiles of PRS. Consumption of a high-fiber diet may be 
an effective weight management strategy for individuals 
carrying a higher number of risk alleles.
Limitations
It is acknowledged that the current study is explorato-
ry and, due to the small sample size, is underpowered to 
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detect a large effect size. However, from the current in-
vestigation we generated several hypotheses. Moreover, 
our study participants were recruited from a specific geo-
graphical location (Beranang, Jalan Broga, and Bandar 
Kajang) and were predominantly women. These factors 
may have influenced the study outcome, and hence the 
findings of the current experiments may not be generaliz-
able to the Malaysian population as a whole. Therefore, 
large-scale studies from other geographical locations are 
required to generalize the findings of the current study to 
the Malaysian population. Further, the trial duration of 
the dietary intervention (6 months) did not allow to in-
vestigate long-term adherence to the intervention diet 
and subsequent weight maintenance. This is a limitation 
of the intervention study.
Body composition was assessed using bioelectrical im-
pedance analysis. This is one of the limitations of this 
study. Many factors such as food and fluid intake, envi-
ronment, ethnicity, and phase of menstrual cycle affect 
bioelectrical impedance analysis estimates. We carefully 
controlled for confounding lifestyle factors and baseline 
values in the analyses. However, detailed information on 
other confounding factors such as individuals’ mental 
health (e.g., stress, sleep problems, worry, depression, 
anxiety), sociodemographic indicators (e.g., location of 
residence, marital status), and socioeconomic indicators 
(e.g., educational attainment, social class, employment 
status, monthly household income, housing tenure) were 
not assessed. These factors may have contributed to the 
variations in the effect of gene-diet interactions on obesi-
ty-related phenotypes in the study participants. Due to 
limited resources, only the most widely reported genes 
FTO and ADRB2 (and their gene variants) [9] were ana-
lyzed in the current study. This study is preliminary in 
nature, and more trials with larger sample size are war-
ranted.
Conclusion
The data from the cross-sectional study revealed that 
individuals with higher PRS were associated with signifi-
cantly increased odds of obesity compared to individuals 
with lower PRS. Malaysian Indians had significantly 
higher PRS compared to Chinese, suggesting that Indians 
were more likely to be genetically predisposed to obesity 
compared to Chinese. Moreover, our results revealed that 
higher PRS was associated with increased WC, fat mass, 
percent body fat, and hsCRP levels compared to lower 
PRS.
The RCT of the current study revealed greater reduc-
tion in hsCRP levels in the second and third tertiles of 
PRS after 6 months of Hipcref diet compared to the con-
trol diet. This study lays out a strategy to manage in-
flammation for overweight and obese individuals who 
are genetically predisposed to obesity. It can be suggest-
ed that the Hipcref diet delivered favorable outcomes in 
weight management and reduced hsCRP levels in the 
current study participants. However, large-scale clinical 
trials are needed to confirm the current findings in oth-
er population groups from other geographical loca-
tions.
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